Anne Heatherington recently joined Takeda Pharmaceuticals as Senior Vice President and Head of Data Sciences Institute (DSI). In this role, she oversees many of the quantitative groups within Takeda, including Statistics and Quantitative Solutions, Global Health Outcomes and Epidemiology and Data Architecture and Digital Solutions. Her mandate is to drive innovation in R&D through focusing on knowledge infrastructure, enabling patient-centricity and developing tools and infrastructure to thoroughly understand the safety and efficacy of Takeda’s medicines.
Anne has over 20 years’ experience leading organizations and programs in large pharma, mid-size biotechs and start-up organizations, including Summit Therapeutics, Pfizer Ltd., and Amgen Inc. She has focused primarily on the application of quantitative principles to clinical drug development and decision-making. Anne received her bachelor’s degree in pharmacy from Queen’s University Belfast, Northern Ireland, and her Ph.D. in pharmacokinetics from the University of Manchester, England. She completed postdoctoral training in the Center for Bioengineering at University of Washington, Seattle.